secwatch.observer — SEC 8-K summary
======================================

Issuer:     LifeStance Health Group, Inc. (LFST)
CIK:        0001845257
Form:       8-K
Filed at:   2021-11-08T23:59:59+00:00
Accession:  0000950170-21-003476
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LifeStance Q3 revenue $173.8M (+70% YoY); net loss $120.5M on stock comp; FY revenue guided to lower end of $668-678M
--------------------------------------------------------------------------------

- Revenue $173.8M, up 70% YoY; Center Margin $52.1M (29.9% of revenue), up 57%.
- Net loss $120.5M vs $3.3M loss a year ago, primarily driven by $120.7M stock/unit-based compensation.
- Adjusted EBITDA $10.7M (6.2% of revenue), down 29% YoY from $15.0M.
- Clinicians grew 72% to 4,375; added 400 net clinicians in Q3; retention stabilized ~80% annualized.
- FY 2021 revenue expected toward lower end of $668-678M range; Center Margin and Adjusted EBITDA guidance unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1845257/000095017021003476/0000950170-21-003476-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1845257/000095017021003476/lfst-20211108.htm
  HTML page:      https://secwatch.observer/filing/0000950170-21-003476

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer